EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Breast-on-a-Chip Microfluidic Model to Assess the Effect of Palbociclib in MCF-7 and T47D Cancer Cells

Ingrid Larissa Melo Souza, Ana Cláudia Martins Braga Gomes Torres iD, Rodrigo Lucas, Isabella Gizzi Jiacomini iD, Sthefanie Ribas Klein, Maíra Barbosa E Reis, Andréia Akemi Suzukawa, Dalila Lucíola Zanette iD, Mateus Nóbrega Aoki iD, Alessandra Melo de Aguiar iD, Bruno Dallagiovanna iD, Lucas Blanes iD

Cells · 2026

DOI: 10.3390/cells15050446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Ingrid Larissa Melo Souza und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Applied Science and Technology in Health (LACTAS), Carlos Chagas Institute, Fiocruz, Curitiba 81350-010, PR, Brazil. Hauptthemen laut MEDLINE: Piperazines, Breast Neoplasms, Lab-On-A-Chip Devices, Pyridines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organ-on-a-chip devices combine microfabrication, tissue engineering, and microfluidics to recreate physiologically relevant microenvironments for in vitro studies. In this work, we validated a dynamic 2D breast-on-a-chip microfluidic bioassay operated at a controlled infusion rate of 20 µL/h to assess anticancer drug responses under defined flow conditions. Using Palbociclib as a reference compound, we evaluated proliferation, viability/apoptosis, cytoskeleton organization, and differential processing of the resistance-associated marker PARP1 in MCF-7 and T47D breast cancer cells. Under dynamic microfluidic conditions, Palbociclib induced dose-dependent effects, with the higher concentration (20 µM) consistently reducing cell proliferation and viability and increasing late apoptosis compared to 10 µM Palbociclib. Cytoskeletal disorganization was observed at both concentrations, while differential PARP1 processing patterns between MCF-7 and T47D cells were detected across doses. These responses are consistent with known effects of CDK4/6 inhibition and were reproducibly captured under controlled flow conditions. Overall, our results demonstrate that this breast-on-a-chip microfluidic model provides a reproducible and physiologically relevant in vitro platform for integrated assessment of drug efficacy and resistance-associated markers under dynamic perfusion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperazinesBreast NeoplasmsLab-On-A-Chip DevicesPyridinesMicrofluidicsAntineoplastic AgentsHumansMCF-7 CellsFemaleCell ProliferationApoptosisCell SurvivalPoly (ADP-Ribose) Polymerase-1Microphysiological SystemsCell Line, TumorCytoskeleton

Stichwörter der Autor:innen

MCF-7PARP1PalbociclibT47Dbreast cancer cellsbreast-on-a-chipmicrofluidics

Substanzen

palbociclibPiperazinesPyridinesPoly (ADP-Ribose) Polymerase-1Antineoplastic AgentsPARP1 protein, human

Autor:innen und Institutionen

  • Laboratory for Applied Science and Technology in Health (LACTAS), Carlos Chagas Institute, Fiocruz, Curitiba 81350-010, PR, Brazil.
  • Laboratory of Basic Biology of Stem Cells (Labcet), Carlos Chagas Institute, Fiocruz, Curitiba 81350-010, PR, Brazil.
  • Alternative Methods for Cytotoxicity Bioassays Platform (RPT11J), Technological Platforms Network FIOCRUZ, Carlos Chagas Institute, Fiocruz, Curitiba 81350-010, PR, Brazil.

ORCID-Profile: Ana Cláudia Martins Braga Gomes Torres, Isabella Gizzi Jiacomini, Dalila Lucíola Zanette, Mateus Nóbrega Aoki, Alessandra Melo de Aguiar, Bruno Dallagiovanna, Lucas Blanes

Förderung

  • National Council for Scientific and Technological Development

Zitieren

APA

Souza, I. L. M., Gomes Torres, A. C. M. B., Lucas, R., Jiacomini, I. G., Klein, S. R., E Reis, M. B., Suzukawa, A. A., Zanette, D. L., Aoki, M. N., de Aguiar, A. M., Dallagiovanna, B., & Blanes, L. (2026). Development of a Breast-on-a-Chip Microfluidic Model to Assess the Effect of Palbociclib in MCF-7 and T47D Cancer Cells. Cells. https://doi.org/10.3390/cells15050446

Vancouver

Souza ILM, Gomes Torres ACMB, Lucas R, Jiacomini IG, Klein SR, E Reis MB, et al. Development of a Breast-on-a-Chip Microfluidic Model to Assess the Effect of Palbociclib in MCF-7 and T47D Cancer Cells. Cells. 2026. doi:10.3390/cells15050446

BibTeX
@article{Souza2026,
  author = {Souza, Ingrid Larissa Melo and Gomes Torres, Ana Cláudia Martins Braga and Lucas, Rodrigo and Jiacomini, Isabella Gizzi and Klein, Sthefanie Ribas and E Reis, Maíra Barbosa and Suzukawa, Andréia Akemi and Zanette, Dalila Lucíola and Aoki, Mateus Nóbrega and de Aguiar, Alessandra Melo and Dallagiovanna, Bruno and Blanes, Lucas},
  title = {Development of a Breast-on-a-Chip Microfluidic Model to Assess the Effect of Palbociclib in MCF-7 and T47D Cancer Cells},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15050446}
}
Kostenlos starten →